| UniProt ID | JUND_HUMAN | |
|---|---|---|
| UniProt AC | P17535 | |
| Protein Name | Transcription factor jun-D | |
| Gene Name | JUND | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 347 | |
| Subcellular Localization | Nucleus. | |
| Protein Description | Transcription factor binding AP-1 sites.. | |
| Protein Sequence | METPFYGDEALSGLGGGASGSGGSFASPGRLFPGAPPTAAAGSMMKKDALTLSLSEQVAAALKPAAAPPPTPLRADGAPSAAPPDGLLASPDLGLLKLASPELERLIIQSNGLVTTTPTSSQFLYPKVAASEEQEFAEGFVKALEDLHKQNQLGAGAAAAAAAAAAGGPSGTATGSAPPGELAPAAAAPEAPVYANLSSYAGGAGGAGGAATVAFAAEPVPFPPPPPPGALGPPRLAALKDEPQTVPDVPSFGESPPLSPIDMDTQERIKAERKRLRNRIAASKCRKRKLERISRLEEKVKTLKSQNTELASTASLLREQVAQLKQKVLSHVNSGCQLLPQHQVPAY | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 3 | Phosphorylation | -----METPFYGDEA -----CCCCCCCHHH | 19.87 | 22210691 | |
| 6 | Phosphorylation | --METPFYGDEALSG --CCCCCCCHHHCCC | 25.52 | 22210691 | |
| 19 | Phosphorylation | SGLGGGASGSGGSFA CCCCCCCCCCCCCCC | 36.44 | 24300666 | |
| 21 | Phosphorylation | LGGGASGSGGSFASP CCCCCCCCCCCCCCC | 37.17 | 29523821 | |
| 24 | Phosphorylation | GASGSGGSFASPGRL CCCCCCCCCCCCCCC | 22.59 | 29523821 | |
| 27 | Phosphorylation | GSGGSFASPGRLFPG CCCCCCCCCCCCCCC | 26.36 | 25159151 | |
| 38 | Phosphorylation | LFPGAPPTAAAGSMM CCCCCCCCHHCCHHC | 28.06 | 21406692 | |
| 43 | Phosphorylation | PPTAAAGSMMKKDAL CCCHHCCHHCHHHCC | 15.81 | 25159151 | |
| 47 | Phosphorylation | AAGSMMKKDALTLSL HCCHHCHHHCCCCCH | 30.27 | 32142685 | |
| 53 | Phosphorylation | KKDALTLSLSEQVAA HHHCCCCCHHHHHHH | 25.31 | 28348404 | |
| 54 | Ubiquitination | KDALTLSLSEQVAAA HHCCCCCHHHHHHHH | 8.00 | 22817900 | |
| 55 | Phosphorylation | DALTLSLSEQVAAAL HCCCCCHHHHHHHHH | 23.70 | 28348404 | |
| 57 | Phosphorylation | LTLSLSEQVAAALKP CCCCHHHHHHHHHCC | 27.12 | 32142685 | |
| 63 | Acetylation | EQVAAALKPAAAPPP HHHHHHHCCCCCCCC | 28.08 | 26051181 | |
| 71 | Phosphorylation | PAAAPPPTPLRADGA CCCCCCCCCCCCCCC | 40.50 | 27050516 | |
| 74 | Phosphorylation | APPPTPLRADGAPSA CCCCCCCCCCCCCCC | 31.66 | 32142685 | |
| 80 | Phosphorylation | LRADGAPSAAPPDGL CCCCCCCCCCCCCCC | 36.21 | 26074081 | |
| 84 | Ubiquitination | GAPSAAPPDGLLASP CCCCCCCCCCCCCCC | 43.50 | 29967540 | |
| 90 | Phosphorylation | PPDGLLASPDLGLLK CCCCCCCCCCCCHHH | 20.93 | 30266825 | |
| 97 | Ubiquitination | SPDLGLLKLASPELE CCCCCHHHHCCHHHH | 47.23 | 21906983 | |
| 99 | Ubiquitination | DLGLLKLASPELERL CCCHHHHCCHHHHHH | 22.81 | 32015554 | |
| 100 | Phosphorylation | LGLLKLASPELERLI CCHHHHCCHHHHHHH | 29.37 | 19664994 | |
| 110 | Phosphorylation | LERLIIQSNGLVTTT HHHHHHHCCCCEEEC | 23.58 | 22199227 | |
| 115 | Phosphorylation | IQSNGLVTTTPTSSQ HHCCCCEEECCCHHH | 29.96 | 22199227 | |
| 116 | Phosphorylation | QSNGLVTTTPTSSQF HCCCCEEECCCHHHH | 24.25 | 22199227 | |
| 117 | Phosphorylation | SNGLVTTTPTSSQFL CCCCEEECCCHHHHC | 18.40 | 25159151 | |
| 117 | O-linked_Glycosylation | SNGLVTTTPTSSQFL CCCCEEECCCHHHHC | 18.40 | 31492838 | |
| 119 | Phosphorylation | GLVTTTPTSSQFLYP CCEEECCCHHHHCCC | 38.63 | 22199227 | |
| 119 | O-linked_Glycosylation | GLVTTTPTSSQFLYP CCEEECCCHHHHCCC | 38.63 | 31492838 | |
| 120 | O-linked_Glycosylation | LVTTTPTSSQFLYPK CEEECCCHHHHCCCE | 24.28 | 31492838 | |
| 120 | Phosphorylation | LVTTTPTSSQFLYPK CEEECCCHHHHCCCE | 24.28 | 28122231 | |
| 121 | Phosphorylation | VTTTPTSSQFLYPKV EEECCCHHHHCCCEE | 27.68 | 22199227 | |
| 121 | O-linked_Glycosylation | VTTTPTSSQFLYPKV EEECCCHHHHCCCEE | 27.68 | 31492838 | |
| 127 | Ubiquitination | SSQFLYPKVAASEEQ HHHHCCCEECCCHHH | 30.83 | 29967540 | |
| 131 | Phosphorylation | LYPKVAASEEQEFAE CCCEECCCHHHHHHH | 31.74 | 25159151 | |
| 142 | Ubiquitination | EFAEGFVKALEDLHK HHHHHHHHHHHHHHH | 45.02 | 32015554 | |
| 212 | Phosphorylation | GGAGGAATVAFAAEP CCCCCCCEEEEECCC | 16.31 | 32142685 | |
| 216 | Phosphorylation | GAATVAFAAEPVPFP CCCEEEEECCCCCCC | 10.94 | 33259812 | |
| 240 | Sumoylation | PPRLAALKDEPQTVP CCCHHHCCCCCCCCC | 56.15 | - | |
| 241 | Ubiquitination | PRLAALKDEPQTVPD CCHHHCCCCCCCCCC | 73.91 | 32015554 | |
| 245 | Phosphorylation | ALKDEPQTVPDVPSF HCCCCCCCCCCCCCC | 44.73 | 23927012 | |
| 251 | Phosphorylation | QTVPDVPSFGESPPL CCCCCCCCCCCCCCC | 45.81 | 26846344 | |
| 255 | Phosphorylation | DVPSFGESPPLSPID CCCCCCCCCCCCCCC | 32.00 | 26846344 | |
| 259 | Phosphorylation | FGESPPLSPIDMDTQ CCCCCCCCCCCCCHH | 26.11 | 26846344 | |
| 265 | Phosphorylation | LSPIDMDTQERIKAE CCCCCCCHHHHHHHH | 26.20 | 30266825 | |
| 282 | Ubiquitination | RLRNRIAASKCRKRK HHHHHHHHHHHHHHH | 13.72 | 23000965 | |
| 284 | Ubiquitination | RNRIAASKCRKRKLE HHHHHHHHHHHHHHH | 33.07 | 23000965 | |
| 294 | Phosphorylation | KRKLERISRLEEKVK HHHHHHHHHHHHHHH | 36.71 | - | |
| 305 | Phosphorylation | EKVKTLKSQNTELAS HHHHHHHHHCHHHHH | 31.60 | 21406692 | |
| 308 | Phosphorylation | KTLKSQNTELASTAS HHHHHHCHHHHHHHH | 25.41 | 20068231 | |
| 312 | Phosphorylation | SQNTELASTASLLRE HHCHHHHHHHHHHHH | 36.81 | 21406692 | |
| 313 | Phosphorylation | QNTELASTASLLREQ HCHHHHHHHHHHHHH | 18.04 | 21406692 | |
| 315 | Phosphorylation | TELASTASLLREQVA HHHHHHHHHHHHHHH | 28.20 | 21406692 | |
| 325 | Ubiquitination | REQVAQLKQKVLSHV HHHHHHHHHHHHHHH | 35.67 | 23000965 | |
| 327 | Ubiquitination | QVAQLKQKVLSHVNS HHHHHHHHHHHHHHC | 43.48 | 23000965 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 100 | S | Phosphorylation | Kinase | JNK1 | P45983 | PSP |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of JUND_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of JUND_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| BRCA1_HUMAN | BRCA1 | physical | 12080089 | |
| RFWD2_HUMAN | RFWD2 | physical | 12615916 | |
| CSN5_HUMAN | COPS5 | physical | 8837781 | |
| MEN1_HUMAN | MEN1 | physical | 9989505 | |
| MK08_HUMAN | MAPK8 | physical | 12052834 | |
| MEN1_HUMAN | MEN1 | physical | 16651450 | |
| EP300_HUMAN | EP300 | physical | 16264271 | |
| MEN1_HUMAN | MEN1 | physical | 10500243 | |
| EP300_HUMAN | EP300 | physical | 17510411 | |
| TYY1_HUMAN | YY1 | physical | 17510411 | |
| ARP3_HUMAN | ACTR3 | physical | 20195357 | |
| CMC1_HUMAN | SLC25A12 | physical | 20195357 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-100; SER-255 ANDSER-259, AND MASS SPECTROMETRY. | |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-100; SER-251; SER-255AND SER-259, AND MASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-100, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-251; SER-255 ANDSER-259, AND MASS SPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-255 AND SER-259, ANDMASS SPECTROMETRY. | |
| "Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-255, AND MASSSPECTROMETRY. | |